Skip to main content
Top
Published in: Dermatology and Therapy 2/2021

Open Access 01-04-2021 | Atopic Dermatitis | Review

Tolerability of and Adherence to Topical Treatments in Atopic Dermatitis: A Narrative Review

Authors: Heather L. Tier, Esther A. Balogh, Arjun M. Bashyam, Alan B. Fleischer Jr, Jonathan M. Spergel, E. J. Masicampo, Lara K. Kammrath, Lindsay C. Strowd, Steven R. Feldman

Published in: Dermatology and Therapy | Issue 2/2021

Login to get access

Abstract

Atopic dermatitis (AD) is a common, chronic inflammatory skin disease that oftentimes requires complex therapy. Poor adherence is a major barrier to AD treatment success. An interspecialty, virtual roundtable panel was held, through which clinical dermatologists, allergists, and behavioral and social psychologists discussed AD management and adherence. Relevant literature was reviewed, and the content of this article was organized based on the roundtable discussion. Current guidelines for AD treatment include maintenance and acute therapy for mild-to-severe AD. Therapy is often complex and requires significant patient involvement, which may contribute to poor treatment adherence. Behavioral and social psychology strategies that may help improve adherence include scheduling timely follow-up appointments, using a clearly written eczema action plan (EAP), reducing perceived treatment burden, utilizing anchoring techniques, sharing anecdotes, and rewarding children using positive reinforcement and stickers. There are multiple practical ways by which providers can improve both the management and treatment adherence of patients with AD.
Literature
1.
go back to reference Draelos ZD, et al. Tolerability of topical treatments for atopic dermatitis. Dermatol Therapy. 2019;9(1):71–102.CrossRef Draelos ZD, et al. Tolerability of topical treatments for atopic dermatitis. Dermatol Therapy. 2019;9(1):71–102.CrossRef
2.
go back to reference Eichenfield LF, et al. Guidelines of care for the management of atopic dermatitis: Section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338–51.CrossRef Eichenfield LF, et al. Guidelines of care for the management of atopic dermatitis: Section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338–51.CrossRef
3.
go back to reference Hay RJ, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Investig Dermatol. 2014;134(6):1527–34.CrossRef Hay RJ, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Investig Dermatol. 2014;134(6):1527–34.CrossRef
4.
go back to reference Silverberg JI. Public health burden and epidemiology of atopic dermatitis. Dermatol Clin. 2017;35(3):283–9.CrossRef Silverberg JI. Public health burden and epidemiology of atopic dermatitis. Dermatol Clin. 2017;35(3):283–9.CrossRef
5.
go back to reference Hsu DY, Shinkai K, Silverberg JI. Epidemiology of eczema herpeticum in hospitalized US children: analysis of a nationwide cohort. J Investig Dermatol. 2018;138(2):265–72.CrossRef Hsu DY, Shinkai K, Silverberg JI. Epidemiology of eczema herpeticum in hospitalized US children: analysis of a nationwide cohort. J Investig Dermatol. 2018;138(2):265–72.CrossRef
6.
go back to reference Margolis JS, et al. Persistence of mild to moderate atopic dermatitis. JAMA Dermatol. 2014;150(6):593–600.CrossRef Margolis JS, et al. Persistence of mild to moderate atopic dermatitis. JAMA Dermatol. 2014;150(6):593–600.CrossRef
7.
go back to reference Feldman SR, et al. The challenge of managing atopic dermatitis in the United States. Am Health Drug Benefits. 2019;12(2):83.PubMedPubMedCentral Feldman SR, et al. The challenge of managing atopic dermatitis in the United States. Am Health Drug Benefits. 2019;12(2):83.PubMedPubMedCentral
8.
go back to reference Patel NU, D’Ambra V, Feldman SR. Increasing adherence with topical agents for atopic dermatitis. Am J Clin Dermatol. 2017;18(3):323–32.CrossRef Patel NU, D’Ambra V, Feldman SR. Increasing adherence with topical agents for atopic dermatitis. Am J Clin Dermatol. 2017;18(3):323–32.CrossRef
9.
go back to reference Krejci-Manwaring J, et al. Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol. 2007;56(2):211–6.CrossRef Krejci-Manwaring J, et al. Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol. 2007;56(2):211–6.CrossRef
10.
go back to reference Lewis D, Feldman S. Practical ways to improve patient adherence. Middletown: CreateSpace Independent Publishing Platform; 2017. Lewis D, Feldman S. Practical ways to improve patient adherence. Middletown: CreateSpace Independent Publishing Platform; 2017.
11.
go back to reference Conde JF, et al. Adherence to clocortolone pivalate cream 0.1% in a pediatric population with atopic dermatitis. Cutis. 2008;81(5):435–41.PubMed Conde JF, et al. Adherence to clocortolone pivalate cream 0.1% in a pediatric population with atopic dermatitis. Cutis. 2008;81(5):435–41.PubMed
12.
go back to reference Brown KL, Krejci-Manwaring J, Tusa MG, Camacho F, Fleischer AB Jr, Balkrishnan R, Feldman SR. Poor compliance with topical corticosteroids for atopic dermatitis despite severe disease. Dermatol Online J. 2008;14(9):13. Brown KL, Krejci-Manwaring J, Tusa MG, Camacho F, Fleischer AB Jr, Balkrishnan R, Feldman SR. Poor compliance with topical corticosteroids for atopic dermatitis despite severe disease. Dermatol Online J. 2008;14(9):13.
13.
go back to reference Yentzer BA, et al. Good adherence and early efficacy using desonide hydrogel for atopic dermatitis: results from a program addressing patient compliance. J Drugs Dermatol JDD. 2010;9(4):324–9.PubMed Yentzer BA, et al. Good adherence and early efficacy using desonide hydrogel for atopic dermatitis: results from a program addressing patient compliance. J Drugs Dermatol JDD. 2010;9(4):324–9.PubMed
14.
go back to reference Ou H-T, Feldman SR, Balkrishnan R. Understanding and improving treatment adherence in pediatric patients. Semin Cutan Med Surg. 2010;29(2):137–40.CrossRef Ou H-T, Feldman SR, Balkrishnan R. Understanding and improving treatment adherence in pediatric patients. Semin Cutan Med Surg. 2010;29(2):137–40.CrossRef
15.
go back to reference Feldman SR, et al. Treatment adherence intervention studies in dermatology and guidance on how to support adherence. Am J Clin Dermatol. 2017;18(2):253–71.CrossRef Feldman SR, et al. Treatment adherence intervention studies in dermatology and guidance on how to support adherence. Am J Clin Dermatol. 2017;18(2):253–71.CrossRef
16.
go back to reference Sagransky MJ, et al. A randomized controlled pilot study of the effects of an extra office visit on adherence and outcomes in atopic dermatitis. Arch Dermatol. 2010;146(12):1428–31.CrossRef Sagransky MJ, et al. A randomized controlled pilot study of the effects of an extra office visit on adherence and outcomes in atopic dermatitis. Arch Dermatol. 2010;146(12):1428–31.CrossRef
17.
go back to reference Feldman SR, et al. Adherence to topical therapy increases around the time of office visits. J Am Acad Dermatol. 2007;57(1):81–3.CrossRef Feldman SR, et al. Adherence to topical therapy increases around the time of office visits. J Am Acad Dermatol. 2007;57(1):81–3.CrossRef
18.
go back to reference Kim HB, et al. Survey on the management of atopic dermatitis. Korean J Asthma Allergy Clin Immunol. 2012;32(1):16–20. Kim HB, et al. Survey on the management of atopic dermatitis. Korean J Asthma Allergy Clin Immunol. 2012;32(1):16–20.
19.
go back to reference Weston W, Lane A, Morelli J. Color textbook of pediatric dermatology. 4th ed. Philadelphia: Mosby Elsevier; 2007. Weston W, Lane A, Morelli J. Color textbook of pediatric dermatology. 4th ed. Philadelphia: Mosby Elsevier; 2007.
20.
go back to reference Boguniewicz M, et al. Atopic dermatitis yardstick: practical recommendations for an evolving therapeutic landscape. Ann Allergy Asthma Immunol. 2018;120(1):10-22.e2.CrossRef Boguniewicz M, et al. Atopic dermatitis yardstick: practical recommendations for an evolving therapeutic landscape. Ann Allergy Asthma Immunol. 2018;120(1):10-22.e2.CrossRef
21.
go back to reference Sastre J, Davila I. Dupilumab: a new paradigm for the treatment of allergic diseases. J Investig Allergol Clin Immunol. 2018;28(3):139–50.CrossRef Sastre J, Davila I. Dupilumab: a new paradigm for the treatment of allergic diseases. J Investig Allergol Clin Immunol. 2018;28(3):139–50.CrossRef
22.
go back to reference Buddenkotte J, Steinhoff M. Pathophysiology and therapy of pruritus in allergic and atopic diseases. Allergy. 2010;65(7):805–21.CrossRef Buddenkotte J, Steinhoff M. Pathophysiology and therapy of pruritus in allergic and atopic diseases. Allergy. 2010;65(7):805–21.CrossRef
23.
go back to reference Suárez AL, et al. Psychoneuroimmunology of psychological stress and atopic dermatitis: pathophysiologic and therapeutic updates. Acta Derm Venereol. 2012;92(1):7–15.CrossRef Suárez AL, et al. Psychoneuroimmunology of psychological stress and atopic dermatitis: pathophysiologic and therapeutic updates. Acta Derm Venereol. 2012;92(1):7–15.CrossRef
24.
go back to reference Feldman S. The parable of the piano teacher. The Dermatologist. 2007;15(8). Feldman S. The parable of the piano teacher. The Dermatologist. 2007;15(8).
25.
go back to reference Rork JF, et al. Parental response to written eczema action plans in children with eczema. Arch Dermatol. 2012;148(3):391–2.CrossRef Rork JF, et al. Parental response to written eczema action plans in children with eczema. Arch Dermatol. 2012;148(3):391–2.CrossRef
26.
go back to reference Bashyam AM, et al. Placebo tailoring improves patient satisfaction of treatment plans in atopic dermatitis. J Am Acad Dermatol. 2020;83:944–6.CrossRef Bashyam AM, et al. Placebo tailoring improves patient satisfaction of treatment plans in atopic dermatitis. J Am Acad Dermatol. 2020;83:944–6.CrossRef
27.
go back to reference Oussedik E, et al. An anchoring-based intervention to increase patient willingness to use injectable medication in psoriasis. JAMA Dermatol. 2017;153(9):932–4.CrossRef Oussedik E, et al. An anchoring-based intervention to increase patient willingness to use injectable medication in psoriasis. JAMA Dermatol. 2017;153(9):932–4.CrossRef
28.
go back to reference Feldman SR, et al. Treatment adherence in dermatology. Cham: Springer; 2019. Feldman SR, et al. Treatment adherence in dermatology. Cham: Springer; 2019.
29.
go back to reference Ruzicka T, et al. Anti-interleukin-31 receptor A Antibody for atopic dermatitis. N Engl J Med. 2017;376(9):826–35.CrossRef Ruzicka T, et al. Anti-interleukin-31 receptor A Antibody for atopic dermatitis. N Engl J Med. 2017;376(9):826–35.CrossRef
30.
go back to reference Schaper-Gerhardt K, et al. The role of the histamine H(4) receptor in atopic dermatitis and psoriasis. Br J Pharmacol. 2020;177(3):490–502.CrossRef Schaper-Gerhardt K, et al. The role of the histamine H(4) receptor in atopic dermatitis and psoriasis. Br J Pharmacol. 2020;177(3):490–502.CrossRef
31.
go back to reference Ko K, et al. Discovery of a novel highly selective histamine H4 receptor antagonist for the treatment of atopic dermatitis. J Med Chem. 2018;61(7):2949–61.CrossRef Ko K, et al. Discovery of a novel highly selective histamine H4 receptor antagonist for the treatment of atopic dermatitis. J Med Chem. 2018;61(7):2949–61.CrossRef
32.
go back to reference Napolitano M, et al. Profile of baricitinib and its potential in the treatment of moderate to severe atopic dermatitis: a short review on the emerging clinical evidence. J Asthma Allergy. 2020;13:89–94.CrossRef Napolitano M, et al. Profile of baricitinib and its potential in the treatment of moderate to severe atopic dermatitis: a short review on the emerging clinical evidence. J Asthma Allergy. 2020;13:89–94.CrossRef
33.
go back to reference Bass AM, Anderson KL, Feldman SR. Interventions to increase treatment adherence in pediatric atopic dermatitis: a systematic review. J Clin Med. 2015;4(2):231–42.CrossRef Bass AM, Anderson KL, Feldman SR. Interventions to increase treatment adherence in pediatric atopic dermatitis: a systematic review. J Clin Med. 2015;4(2):231–42.CrossRef
Metadata
Title
Tolerability of and Adherence to Topical Treatments in Atopic Dermatitis: A Narrative Review
Authors
Heather L. Tier
Esther A. Balogh
Arjun M. Bashyam
Alan B. Fleischer Jr
Jonathan M. Spergel
E. J. Masicampo
Lara K. Kammrath
Lindsay C. Strowd
Steven R. Feldman
Publication date
01-04-2021
Publisher
Springer Healthcare
Published in
Dermatology and Therapy / Issue 2/2021
Print ISSN: 2193-8210
Electronic ISSN: 2190-9172
DOI
https://doi.org/10.1007/s13555-021-00500-4

Other articles of this Issue 2/2021

Dermatology and Therapy 2/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.